- Playtech Software Ltd: in a patent dispute before the Unified Patent Court concerning an online gaming system.
- GSK (Tesaro): in Court of Appeal proceedings regarding a dispute with AstraZeneca over the patent licence for Zejula, GSK’s PARP-inhibitor cancer product.
- ViiV Healthcare, Shionogi, GSK: in a cross-border patent litigation relating to Gilead's blockbuster HIV treatment, Bictegravir.
- Regeneron and Sanofi: in a cross-border patent litigation against Amgen in the UK, France, Germany and beyond, regarding a revolutionary new class of cholesterol-lowering antibody treatments.
- Intel: in relation to a patent infringement action by Intellectual Ventures II against internet provider Orange in Germany relating to a patent essential to the ADSL standards.
- Seoul Viosys (a sister company of Seoul Semiconductor): advising on and representing in an enforcement campaign at the UPC, concerning patents for a new complex technology increasing the overall efficiency of LEDs.
Our experienced cross-border Intellectual Property team advises market-leading companies on high-profile IP litigation and complex IP-driven transactions and advisory matters